Efficacy and safety profile of angiotensin receptor neprilysin inhibitors in the management of heart failure: a systematic review and meta-analysis of randomized controlled trials

Several guidelines have recommended the use of angiotensin receptor neprilysin inhibitors (ARNIs) as replacement for angiotensin-converting enzyme inhibitors in the management of heart failure. Till date, there are no reviews done that comprehensively cover different aspects of efficacy and safety p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Juan, Zhao, Cong, Zhang, Wen-Zhong, Liu, Song, Xin, Hui, Lian, Zhe-Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289972/
https://www.ncbi.nlm.nih.gov/pubmed/36184714
http://dx.doi.org/10.1007/s10741-022-10273-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289972/
https://www.ncbi.nlm.nih.gov/pubmed/36184714
http://dx.doi.org/10.1007/s10741-022-10273-3

Ejemplares similares